To confirm that DN T cells are able to inhibit allogeneic CD4+ T cell-induced GVHD, we purified preactivated B6.lpr DN T cells and administered them to CB6F1 recipients of B6 BM and B6. This evidence concerns the gene CD4 and graft versus host disease.